These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34993259)

  • 1. Invasive Mold Infections in Allogeneic Hematopoietic Cell Transplant Recipients in 2020: Have We Made Enough Progress?
    Roth RS; Masouridi-Levrat S; Chalandon Y; Mamez AC; Giannotti F; Riat A; Fischer A; Poncet A; Glampedakis E; Van Delden C; Kaiser L; Neofytos D
    Open Forum Infect Dis; 2022 Jan; 9(1):ofab596. PubMed ID: 34993259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology, outcomes, and mortality predictors of invasive mold infections among transplant recipients: a 10-year, single-center experience.
    Neofytos D; Treadway S; Ostrander D; Alonso CD; Dierberg KL; Nussenblatt V; Durand CM; Thompson CB; Marr KA
    Transpl Infect Dis; 2013 Jun; 15(3):233-42. PubMed ID: 23432974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-Life Considerations on Antifungal Treatment Combinations for the Management of Invasive Mold Infections after Allogeneic Cell Transplantation.
    Glampedakis E; Roth R; Masouridi-Levrat S; Chalandon Y; Mamez AC; Giannotti F; Van Delden C; Neofytos D
    J Fungi (Basel); 2021 Sep; 7(10):. PubMed ID: 34682233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential systematic anti-mold prophylaxis with micafungin and voriconazole results in very low incidence of invasive mold infections in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Rosillo C; Avila AM; Huang YT; Devlin S; Cho C; Montoro J; Maloy MA; Papanicolaou GA; Barba P; Perales MA
    Transpl Infect Dis; 2018 Aug; 20(4):e12897. PubMed ID: 29668073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid Biopsy for Invasive Mold Infections in Hematopoietic Cell Transplant Recipients With Pneumonia Through Next-Generation Sequencing of Microbial Cell-Free DNA in Plasma.
    Hill JA; Dalai SC; Hong DK; Ahmed AA; Ho C; Hollemon D; Blair L; Maalouf J; Keane-Candib J; Stevens-Ayers T; Boeckh M; Blauwkamp TA; Fisher CE
    Clin Infect Dis; 2021 Dec; 73(11):e3876-e3883. PubMed ID: 33119063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of solid organ transplant recipients with invasive aspergillosis and other mold infections.
    Farges C; Cointault O; Murris M; Lavayssiere L; Lakhdar-Ghazal S; Del Bello A; Hebral AL; Esposito L; Nogier MB; Sallusto F; Iriart X; Charpentier E; Guitard J; Muscari F; Dambrin C; Porte L; Kamar N; Cassaing S; Faguer S
    Transpl Infect Dis; 2020 Feb; 22(1):e13200. PubMed ID: 31630477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Antifungal Prophylaxis Continuation or Discontinuation After Allogeneic Hematopoietic Cell Transplant on the Incidence of Invasive Mold Infection.
    Ross JA; Lee B; Ma H; Tegtmeier B; Nanayakkara D; Dickter J; Spielberger R; Smith E; Pullarkat V; Forman SJ; Taplitz R; Nakamura R; Al Malki M; Dadwal SS
    Open Forum Infect Dis; 2024 Aug; 11(8):ofae409. PubMed ID: 39135965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Invasive Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: The Turin Experience.
    Busca A; Cinatti N; Gill J; Passera R; Dellacasa CM; Giaccone L; Dogliotti I; Manetta S; Corcione S; De Rosa FG
    Front Cell Infect Microbiol; 2021; 11():805514. PubMed ID: 35071052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors and Outcomes of Invasive Fungal Infections in Allogeneic Hematopoietic Cell Transplant Recipients.
    Miceli MH; Churay T; Braun T; Kauffman CA; Couriel DR
    Mycopathologia; 2017 Jun; 182(5-6):495-504. PubMed ID: 28124219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Clostridioides difficile infection characterizations, risks, and outcomes in allogeneic hematopoietic stem cell and solid organ transplant recipients.
    Obeid KM; Sapkota S; Cao Q; Richmond S; Watson AP; Karadag FK; Young JH; Pruett T; Weisdorf DJ; Ustun C
    Transpl Infect Dis; 2022 Feb; 24(1):e13720. PubMed ID: 34455662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive mold infections in lung and heart-lung transplant recipients: Stanford University experience.
    Vazquez R; Vazquez-Guillamet MC; Suarez J; Mooney J; Montoya JG; Dhillon GS
    Transpl Infect Dis; 2015 Apr; 17(2):259-66. PubMed ID: 25648194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation.
    Garcia-Vidal C; Upton A; Kirby KA; Marr KA
    Clin Infect Dis; 2008 Oct; 47(8):1041-50. PubMed ID: 18781877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive mold infections in acute leukemia patients undergoing allogeneic hematopoietic stem cell transplantation.
    Chien SH; Liu YC; Liu CJ; Ko PS; Wang HY; Hsiao LT; Chiou TJ; Liu JH; Gau JP
    J Microbiol Immunol Infect; 2019 Dec; 52(6):973-982. PubMed ID: 30322746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and outcome of invasive fungal diseases after allogeneic hematopoietic stem cell transplantation: A Swiss transplant cohort study.
    Kuster S; Stampf S; Gerber B; Baettig V; Weisser M; Gerull S; Medinger M; Passweg J; Schanz U; Garzoni C; Berger C; Chalandon Y; Mueller NJ; van Delden C; Neofytos D; Khanna N;
    Transpl Infect Dis; 2018 Dec; 20(6):e12981. PubMed ID: 30144374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for invasive mold infections following allogeneic hematopoietic stem cell transplantation: a single center study of 190 recipients.
    Li L; Wang J; Zhang W; Yang J; Chen L; Lv S
    Scand J Infect Dis; 2012 Feb; 44(2):100-7. PubMed ID: 22066677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial Quantitation of Plasma Microbial Cell-Free DNA Before and After Diagnosis of Pulmonary Invasive Mold Infections After Hematopoietic Cell Transplant.
    Heldman MR; Ahmed AA; Liu W; Vo A; Keane-Candib J; Stevens-Ayers T; Boeckh M; Blauwkamp TA; Fisher CE; Hill JA
    J Infect Dis; 2024 Feb; 229(2):576-587. PubMed ID: 37405403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of pretransplant serum ferritin level on risk of invasive mold infection after allogeneic hematopoietic stem cell transplantation.
    Dadwal SS; Tegtmeier B; Liu X; Frankel P; Ito J; Forman SJ; Pullarkat V
    Eur J Haematol; 2015 Mar; 94(3):235-42. PubMed ID: 25082161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal Treatment Duration in Hematology Patients With Invasive Mold Infections: A Real-life Update.
    Portillo V; Ragozzino S; Stavropoulou E; El-Khoury C; Bochud PY; Lamoth F; Khanna N; Neofytos D
    Open Forum Infect Dis; 2024 May; 11(5):ofae201. PubMed ID: 38756760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When and how do we stop antifungal treatment for an invasive mould infection in allogeneic haematopoietic cell transplant recipients?
    Roth RS; Masouridi-Levrat S; Giannotti F; Mamez AC; Morin S; van Delden C; Chalandon Y; Neofytos D
    Mycoses; 2022 Nov; 65(11):1061-1067. PubMed ID: 35815918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency and causes of antifungal treatment changes in allogeneic haematopoïetic cell transplant recipients with invasive mould infections.
    Roth RS; Masouridi-Levrat S; Giannotti F; Mamez AC; Glambedakis E; Lamoth F; Bochud PY; Erard V; Emonet S; Van Delden C; Kaiser L; Chalandon Y; Neofytos D
    Mycoses; 2022 Feb; 65(2):199-210. PubMed ID: 34936143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.